
All Primary Antibodies
Primary antibodies, immunoglobulins that bind to specific proteins or other biomolecules, are used in many research applications and protocols to detect targets of interest. They are developed using different animal hosts, including mouse, rat, rabbit, goat, sheep, and many others.
Monoclonal and Polyclonal Antibodies
One type of primary antibodies, monoclonal antibodies, provides high reproducibility and low cross-reactivity and background noise. Another type, polyclonal antibodies, often costs less and provides greater affinity and quicker binding. Both are produced using plasma B cells, but the former uses the same clone and the latter uses different clones. Monoclonal antibodies require hybridoma cell lines, and polyclonal antibodies do not.
There are also recombinant monoclonal antibodies with similar benefits, like high affinity, scalability, and specificity. They are produced using in vitro cloning of plasma B cells and expression hosts.
Conjugated Primary Antibodies
Antibodies can be labeled with various fluorophores or detection agents or used without labels. Labeled primary antibodies, also known as conjugated primary antibodies, help researchers simplify and streamline their applications. They are coupled with common enzymes and dyes such as Alexa Fluor and often used in protein and cell analysis.
Applications
Antibodies for life sciences applications are used in flow cytometry, western blotting, ELISA, immunohistochemistry, and immunocytochemistry. Secondary antibodies can be added to support the detection and purification of certain antigens. They bind to the primary antibody, which binds to the antigen of interest. Finding the right combination of antibodies can result in greater antigen specificity and a strong, detectable signal.
- (3)
- (6)
- (2)
- (2)
- (1)
- (3)
- (2)
- (55)
- (1,414)
- (4)
- (2)
- (33)
- (225)
- (10)
- (5)
- (5)
- (64)
- (39,765)
- (2)
- (83,903)
- (7,698)
- (21)
- (283)
- (869)
- (1)
- (6)
- (252)
- (1)
- (2)
- (1)
- (3)
- (39)
- (23)
- (2)
- (4)
- (13)
- (1)
- (1,047)
- (137)

Applications | Immunocytochemistry,Western Blot |
---|---|
Type de produit | Antibody |
Isotype | IgG |
Conjugué | Unconjugated |
Espèces cibles | Human |
Concentration | 0.5 mg/mL |
Primaire ou secondaire | Primary |
Forme | Liquid |
Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
État réglementaire | RUO |
Numéro d’ordre du gène | P68431, Q71DI3 |
Immunogène | Peptide corresponding to Human HIST1H3A (aa 24-31). |
Expression | H3C15 |
Classification | Polyclonal |
Identification génétique (Entrez) | 126961, 333932, 8350, 8356, 8357, 8358, 8968 |
Méthode de purification | Affinity Chromatography |
Espèces hôtes | Rabbit |
Symboles de gène(s) | H3C1, H3C10, H3C12, H3C14, H3C15, H3C2, H3C7 |
Formule | PBS with 0.1% BSA, 30% glycerol and 0.09% sodium azide; pH 7.2 |
Alias de gène | dimethyl H3; di-methyl H3; Dimethyl Histone H3; di-methyl histone H3; Di-Methyl-H3 K27; Di-Methyl-H3 Lys27; Di-Methyl-Histone H3 K27; Di-Methyl-Histone H3 Lys27; Di-Tri-Methyl-Histone H3 K27; Di-Tri-Methyl-Histone H3 Lys27; H3; H3 histone; H3 histone family, member A; H3 histone family, member I; H3 histone family, member K; H3 histone family, member L; H3 histone family, member M; H3 histone, family 2; H3 histone, family 3A; H3 histone, family 3B; H3 histone, family 3B (H3.3B); H3 histone, family 3B.1; H3 histone, family 3C; H3 K27me2; H3.1-221; H3.1-291; H3.1-I; H3.2; H3.2-221; H3.2-614; H3.2-615; H3.2-616; H3.3A; H3.3B; H3.5; H3/A; H3/b; H3/d; H3/f; H3/i; H3/j; H3/k; H3/l; H3/M; H3/n; H3/o; H3-143; H3-291; H3-3A; H3-3B; h3-5; H3-53; H3-614; H3a; H3b; H3-B; H3C1; H3c10; H3c11; H3C12; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3f; H3-F; H3F1K; H3F2; H3F3; h3f3a; H3F3B; h3f3b.1; h3f3c; h3f3d; H3FA; H3FB; H3FC HIST1H3C; H3FD; H3FF; H3FH; H3FI; H3FJ; H3FK; H3FL; H3FM; H3FN; H3g; H3h; H3i; H3k27; H3K27me2/3; H3K27me2me3; H3Lys27me2; H3Lys27me2/3; H3Lys27me2me3; Hist1; HIST1H3A; HIST1H3B; Hist1h3c; HIST1H3D; Hist1h3e; HIST1H3F; Hist1h3g; HIST1H3H; HIST1H3I; HIST1H3J; HIST2H3A; Hist2h3b; HIST2H3C; Hist2h3c1; Hist2h3c2; Hist2h3c2-ps; Hist2h3ca1; Hist2h3ca2; HIST2H3D; histone 1, H3a; histone 1, H3b; histone 1, H3f; histone 1, H3h; histone 2, H3a; histone 2, H3c; histone 2, H3c2; histone 2, H3ca2; Histone 3; histone cluster 1, H3a; histone cluster 1, H3b; histone cluster 1, H3f; histone cluster 1, H3h; histone cluster 2, H3a; histone cluster 2, H3c; histone cluster 2, H3c2; histone cluster 2, H3c2, pseudogene; histone gene complex 1; histone H3; histone H3.1; Histone H3.2; histone H3.3; Histone H3.3C; histone H3.5; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; histone H3/l; Histone H3/m; histone H3/o; Histone H3K27; Histone H3K27me2; histone variant H3.5; hypothetical protein LOC550262; M32461; methyl Histone 3; methyl Histone H3; PP781; wu:fa25h06; wu:fa96g06; wu:fb07a08; wu:fb36f01; zgc:110292; zgc:174300; zgc:56193; zgc:56418; zgc:64222; zgc:86731 |
Antigène | H3K27me2 |
CHD4 Recombinant Human Monoclonal Antibody (K49015_15E2), Invitrogen™
Human Recombinant Monoclonal Antibody
Applications | ELISA,Western Blot |
---|---|
Type de produit | Antibody |
Isotype | IgG1 |
Conjugué | Unconjugated |
Espèces cibles | Human |
Concentration | 1 mg/mL |
Primaire ou secondaire | Primary |
Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
Forme | Liquid |
État réglementaire | RUO |
Numéro d’ordre du gène | Q14839 |
Immunogène | Recombinant human CHD4 (immunogen range is 1291-1550). |
Expression | CHD4 |
Classification | Recombinant Monoclonal |
Identification génétique (Entrez) | 1108 |
Méthode de purification | Protein A |
Espèces hôtes | Human |
Formule | PBS with 0.09% sodium azide |
Alias de gène | 9530019N15Rik; AA617397; ATP-dependent helicase CHD4; BC005710; Chd4; CHD-4; chromodomain helicase DNA binding protein 4; chromodomain-helicase-DNA-binding protein 4; D6Ertd380e; Mi-2; Mi-2 autoantigen; Mi-2 autoantigen 218 kDa protein; Mi-2 beta; MI2B; Mi-2b; Mi-2beta; Mi2-BETA; mKIAA4075 |
Clone | K49015_15E2 |
Antigène | CHD4 |
Applications | Western Blot |
---|---|
Type de produit | Antibody |
Isotype | IgG1 |
Conjugué | Unconjugated |
Espèces cibles | Human,Mouse |
Concentration | 1 mg/mL |
Primaire ou secondaire | Primary |
Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
Forme | Liquid |
État réglementaire | RUO |
Numéro d’ordre du gène | P21246, P63089 |
Immunogène | Recombinant human PTN (proprietary range information). |
Expression | PTN |
Classification | Monoclonal |
Identification génétique (Entrez) | 19242, 5764 |
Méthode de purification | Protein A |
Espèces hôtes | Mouse |
Formule | PBS with 0.09% sodium azide |
Alias de gène | HARP; HBBM; HBBN; HB-GAM; HBGF8; HBGF-8; HBNF; HBNF1; HBNF-1; heparin affin regulatory peptide; heparin affin regulatory protein; heparin binding factor; heparin-binding brain mitogen; Heparin-binding growth factor 8; heparin-binding growth-associated molecule; heparin-binding neurite outgrowth promoting factor; Heparin-binding neurite outgrowth-promoting factor; Heparin-binding neurite outgrowth-promoting factor 1; heparin-binding neurite promoting factor; heparin-binding neurotorphic factor; heparin-binding neutrophic factor; NEGF1; OSF; Osf1; OSF-1; osteoblastic cell factor; Osteoblast-specific factor 1; pleiotrophin; pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1); Pleiotrophin (Heparine binding factor, Hbnf, in the mouse); PTN |
Clone | K06279_4G7 |
Antigène | Pleiotrophin |
Applications | Immunohistochemistry (Paraffin) |
---|---|
Type de produit | Antibody |
Isotype | IgG1 κ |
Conjugué | Alexa Fluor Plus 594 |
Espèces cibles | Human |
Concentration | 0.2 mg/mL |
Primaire ou secondaire | Primary |
Forme | Liquid |
Contenu et stockage | 4°C, store in dark |
État réglementaire | RUO |
Numéro d’ordre du gène | P18827 |
Immunogène | A mixture of U266 and XG-1 human myeloma cell lines. |
Expression | Sdc1 |
Classification | Monoclonal |
Identification génétique (Entrez) | 6382 |
Méthode de purification | Protein A |
Espèces hôtes | Mouse |
Symboles de gène(s) | Sdc1 |
Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Alias de gène | AA408134; AA409076; CD antigen 138; CD138; CD138 antigen; heparan sulfate proteoglycan fibroblast growth factor receptor; HSPG; sCD138; SDC; Sdc1; soluble CD138; Sstn; syn-1; Synd; SYND1; Synd-1; SYNDECA; syndecan; syndecan 1; syndecan proteoglycan 1; Syndecan1; syndecan-1; synstatin |
Clone | MI15 |
Antigène | CD138 |
Applications | Immunohistochemistry (Paraffin) |
---|---|
Type de produit | Antibody |
Isotype | IgG2b κ |
Conjugué | Alexa Fluor Plus 647 |
Espèces cibles | Human |
Concentration | 0.2 mg/mL |
Primaire ou secondaire | Primary |
Forme | Liquid |
Contenu et stockage | 4°C, store in dark |
État réglementaire | RUO |
Numéro d’ordre du gène | P01730 |
Expression | CD4 |
Classification | Monoclonal |
Identification génétique (Entrez) | 920 |
Méthode de purification | Affinity chromatography |
Espèces hôtes | Mouse |
Symboles de gène(s) | CD4 |
Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Alias de gène | Activation B7-1 antigen; B7; B7.1; B7-1; BB1; B-lymphocyte activation antigen B7; CD28LG; CD28LG1; CD4; CD4 antigen; CD4 antigen (p55); CD4 antigen p55; Cd4 molecule; CD4 precursor; CD4 receptor; CD4, allele 1; cd4a; CD4mut; CD80; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 molecule; cell surface glycoprotein CD4; costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; fCD4; L3T4; LAB7; Leu-3; Ly-4; lymphocyte antigen CD4; lymphocyte antigen CD4 precursor; membrane protein; p55; T-cell differentiation antigen L3T4; T-cell surface antigen T4/Leu-3; T-cell surface glycoprotein CD4; T-cell surface glycoprotein CD4 precursor (T-cell surface antigen T4/Leu-3) (T-cell differentiation antigen L3T4); T-lymphocyte activation antigen CD80; W3/25; W3/25 antigen |
Clone | N1UG0 |
Antigène | CD4 |
Applications | Immunohistochemistry (Paraffin) |
---|---|
Type de produit | Antibody |
Isotype | IgG2b κ |
Conjugué | Alexa Fluor Plus 750 |
Espèces cibles | Human |
Concentration | 0.2 mg/mL |
Primaire ou secondaire | Primary |
Forme | Liquid |
Contenu et stockage | 4°C, store in dark |
État réglementaire | RUO |
Numéro d’ordre du gène | P02462, P08572, P29400, P53420, Q01955, Q14031 |
Expression | COL4A2 |
Classification | Monoclonal |
Identification génétique (Entrez) | 1282, 1284, 1285, 1286, 1287, 1288 |
Méthode de purification | Affinity Chromatography |
Espèces hôtes | Mouse |
Symboles de gène(s) | COL4A1, COL4A2, Col4a3, COL4A4, COL4A5, COL4A6 |
Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Alias de gène | [a]3(IV); [a]4(IV); alpha 1 type IV collagen; alpha type IV collagen basement membrane; alpha1(IV) collagen; alpha-2 collagen type IV; alpha-3 type IV collagen; alpha3(IV); Arresten; Bru; BSVD; CA44; Canstatin; Col4a1; Col4a-1; COL4A1 NC1 domain; Col4a2; Col4a-2; COL4A3; col4a4; Collagen 4; Collagen alpha-1(IV) chain; collagen alpha-2(IV) chain; Collagen alpha-3(IV) chain; collagen alpha-4(IV) chain; collagen IV, alpha-1 polypeptide; collagen IV, alpha-3 polypeptide; Collagen IV, alpha-4 polypeptide; collagen of basement membrane, alpha-1 chain; collagen of basement membrane, alpha-4 chain; collagen type IV alpha 1 chain; collagen type IV alpha 2; collagen type IV alpha 2 chain; collagen type IV alpha 3 chain; collagen type IV alpha 4 chain; collagen type IV alpha3 chain; collagen, type IV, alpha 1; collagen, type IV, alpha 2; collagen, type IV, alpha 3; collagen, type IV, alpha 3 (Goodpasture antigen); collagen, type IV, alpha 4; Del(8)44H; Del(8)Bru44H; E130010M05Rik; Goodpasture antigen; ICH; LOW QUALITY PROTEIN: collagen alpha-1(IV) chain; LOW QUALITY PROTEIN: collagen alpha-3(IV) chain; LOW QUALITY PROTEIN: collagen alpha-4(IV) chain; POREN2; procollagen alpha1(IV); procollagen, type IV, alpha 1; procollagen, type IV, alpha 2; procollagen, type IV, alpha 3; procollagen, type IV, alpha 4; RATOR; Raw; retinal anterior wiring; Svc; tumstatin; Type IV Collagen |
Clone | 1042 |
Antigène | Collagen IV |
Applications | Immunohistochemistry (Paraffin) |
---|---|
Type de produit | Antibody |
Isotype | IgG2a |
Conjugué | Alexa Fluor Plus 555 |
Espèces cibles | Human |
Concentration | 0.2 mg/mL |
Primaire ou secondaire | Primary |
Forme | Liquid |
Contenu et stockage | 4°C, store in dark |
État réglementaire | RUO |
Numéro d’ordre du gène | P12004 |
Immunogène | Rat recombinant PCNA polypeptides. |
Expression | Pcna |
Classification | Monoclonal |
Identification génétique (Entrez) | 5111 |
Méthode de purification | Purified |
Espèces hôtes | Mouse |
Symboles de gène(s) | Pcna |
Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Alias de gène | ATLD2; cb16; Cyclin; DNA polymerase delta auxiliary protein; etID36690.10; fa28e03; fb36g03; HGCN8729; hypothetical protein LOC515499; MGC8367; Pcna; pcna protein; Pcna/cyclin; PCNAR; POL30; Proliferating cell nuclear antigen; wu:fa28e03; wu:fb36g03; YBR0811; YBR088C |
Clone | PC10 |
Antigène | PCNA |
Applications | Immunohistochemistry (Paraffin) |
---|---|
Type de produit | Antibody |
Isotype | IgG2b κ |
Conjugué | Alexa Fluor Plus 594 |
Espèces cibles | Human |
Concentration | 0.2 mg/mL |
Primaire ou secondaire | Primary |
Forme | Liquid |
Contenu et stockage | 4°C, store in dark |
État réglementaire | RUO |
Numéro d’ordre du gène | P01730 |
Expression | CD4 |
Classification | Monoclonal |
Identification génétique (Entrez) | 920 |
Méthode de purification | Affinity Chromatography |
Espèces hôtes | Mouse |
Symboles de gène(s) | CD4 |
Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Alias de gène | Activation B7-1 antigen; B7; B7.1; B7-1; BB1; B-lymphocyte activation antigen B7; CD28LG; CD28LG1; CD4; CD4 antigen; CD4 antigen (p55); CD4 antigen p55; Cd4 molecule; CD4 precursor; CD4 receptor; CD4, allele 1; cd4a; CD4mut; CD80; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 molecule; cell surface glycoprotein CD4; costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; fCD4; L3T4; LAB7; Leu-3; Ly-4; lymphocyte antigen CD4; lymphocyte antigen CD4 precursor; membrane protein; p55; T-cell differentiation antigen L3T4; T-cell surface antigen T4/Leu-3; T-cell surface glycoprotein CD4; T-cell surface glycoprotein CD4 precursor (T-cell surface antigen T4/Leu-3) (T-cell differentiation antigen L3T4); T-lymphocyte activation antigen CD80; W3/25; W3/25 antigen |
Clone | N1UG0 |
Antigène | CD4 |
Invitrogen™ CD8 alpha Monoclonal Antibody (C8/144B), Alexa Fluor™ Plus 647
Mouse Monoclonal Antibody
Applications | Immunohistochemistry (Paraffin) |
---|---|
Type de produit | Antibody |
Isotype | IgG1 κ |
Conjugué | Alexa Fluor Plus 647 |
Espèces cibles | Human |
Concentration | 0.2 mg/mL |
Primaire ou secondaire | Primary |
Forme | Liquid |
Contenu et stockage | 4°C, store in dark |
État réglementaire | RUO |
Numéro d’ordre du gène | P01732, P10966 |
Immunogène | A 13 amino acid synthetic peptide from the C-terminal cytoplasmic domain of alpha chain of human CD8 molecule. |
Expression | CD8B |
Classification | Monoclonal |
Identification génétique (Entrez) | 925, 926 |
Méthode de purification | Affinity Chromatography |
Espèces hôtes | Mouse |
Symboles de gène(s) | Cd8a, CD8B |
Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Alias de gène | BB154331; CD8; CD8 alpha; CD8 alpha chain; CD8 alpha chain precursor; CD8 antigen; CD8 antigen 32 kDa chain; CD8 antigen 37 kDa chain; CD8 antigen alpha polypeptide; CD8 antigen alpha protein; CD8 antigen alpha protein precursor; CD8 antigen alpha-chain; CD8 antigen beta polypeptide; CD8 antigen beta polypeptide precursor; CD8 antigen beta-chain; CD8 antigen, alpha chain; CD8 antigen, alpha polypeptide; CD8 antigen, alpha polypeptide (p32); CD8 antigen, alpha-chain; CD8 antigen, beta chain; CD8 antigen, beta chain 1; CD8 antigen, beta polypeptide; CD8 antigen, beta polypeptide 1 (p37); CD8 antigen, beta-chain; CD8 beta; CD8 beta chain; CD8 beta-2; CD8a; CD8A antigen alpha; CD8a molecule; CD8A; T-cell surface glycoprotein; CD8alpha; CD8B; CD8b antigen; CD8b molecule; CD8b molecule pseudogene; Cd8b1; CD8beta; CD8BP; fCD8; LEU2; Leu-2; Leu2 T-lymphocyte antigen; leu-2a; Ly-2; LY3; Ly-3; Ly-35; Ly-B; Ly-C; Lymphocyte antigen 3; Lyt2; Lyt-2; Lyt-2.1 lymphocyte differentiation antigen (AA at 100); Lyt3; Lyt-3; MAL; membrane glycoprotein; membrane protein; OKT8 T-cell antigen; OX-8 membrane antigen; p32; P37; RHACD8-4; T cell co-receptor; T lymphocyte surface glycoprotein beta chain; T8 T-cell antigen; T-cell antigen Leu2; T-cell membrane glycoprotein Ly-3; T-cell surface glycoprotein; T-cell surface glycoprotein CD8 alpha chain; T-cell surface glycoprotein CD8 beta chain; T-cell surface glycoprotein Lyt-2; T-cell surface glycoprotein Lyt-3; T-cell surface molecule; T-lymphocyte differentiation antigen T8/Leu-2; type I transmembrane glycoprotein |
Clone | C8/144B |
Antigène | CD8 alpha |
Applications | Immunohistochemistry (Paraffin) |
---|---|
Type de produit | Antibody |
Isotype | IgG1 κ |
Conjugué | Alexa Fluor Plus 647 |
Espèces cibles | Human |
Concentration | 0.2 mg/mL |
Primaire ou secondaire | Primary |
Forme | Liquid |
Contenu et stockage | 4°C, store in dark |
État réglementaire | RUO |
Numéro d’ordre du gène | P18827 |
Immunogène | A mixture of U266 and XG-1 human myeloma cell lines. |
Expression | Sdc1 |
Classification | Monoclonal |
Identification génétique (Entrez) | 6382 |
Méthode de purification | Protein A |
Espèces hôtes | Mouse |
Symboles de gène(s) | Sdc1 |
Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Alias de gène | AA408134; AA409076; CD antigen 138; CD138; CD138 antigen; heparan sulfate proteoglycan fibroblast growth factor receptor; HSPG; sCD138; SDC; Sdc1; soluble CD138; Sstn; syn-1; Synd; SYND1; Synd-1; SYNDECA; syndecan; syndecan 1; syndecan proteoglycan 1; Syndecan1; syndecan-1; synstatin |
Clone | MI15 |
Antigène | CD138 |
Applications | Immunohistochemistry (Paraffin) |
---|---|
Type de produit | Antibody |
Isotype | IgG2b κ |
Conjugué | Alexa Fluor Plus 594 |
Espèces cibles | Human |
Concentration | 0.2 mg/mL |
Primaire ou secondaire | Primary |
Forme | Liquid |
Contenu et stockage | 4°C, store in dark |
État réglementaire | RUO |
Numéro d’ordre du gène | P02462, P08572, P29400, P53420, Q01955, Q14031 |
Expression | COL4A2 |
Classification | Monoclonal |
Identification génétique (Entrez) | 1282, 1284, 1285, 1286, 1287, 1288 |
Méthode de purification | Affinity chromatography |
Espèces hôtes | Mouse |
Symboles de gène(s) | COL4A1, COL4A2, Col4a3, COL4A4, COL4A5, COL4A6 |
Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Alias de gène | [a]3(IV); [a]4(IV); alpha 1 type IV collagen; alpha type IV collagen basement membrane; alpha1(IV) collagen; alpha-2 collagen type IV; alpha-3 type IV collagen; alpha3(IV); Arresten; Bru; BSVD; CA44; Canstatin; Col4a1; Col4a-1; COL4A1 NC1 domain; Col4a2; Col4a-2; COL4A3; col4a4; Collagen 4; Collagen alpha-1(IV) chain; collagen alpha-2(IV) chain; Collagen alpha-3(IV) chain; collagen alpha-4(IV) chain; collagen IV, alpha-1 polypeptide; collagen IV, alpha-3 polypeptide; Collagen IV, alpha-4 polypeptide; collagen of basement membrane, alpha-1 chain; collagen of basement membrane, alpha-4 chain; collagen type IV alpha 1 chain; collagen type IV alpha 2; collagen type IV alpha 2 chain; collagen type IV alpha 3 chain; collagen type IV alpha 4 chain; collagen type IV alpha3 chain; collagen, type IV, alpha 1; collagen, type IV, alpha 2; collagen, type IV, alpha 3; collagen, type IV, alpha 3 (Goodpasture antigen); collagen, type IV, alpha 4; Del(8)44H; Del(8)Bru44H; E130010M05Rik; Goodpasture antigen; ICH; LOW QUALITY PROTEIN: collagen alpha-1(IV) chain; LOW QUALITY PROTEIN: collagen alpha-3(IV) chain; LOW QUALITY PROTEIN: collagen alpha-4(IV) chain; POREN2; procollagen alpha1(IV); procollagen, type IV, alpha 1; procollagen, type IV, alpha 2; procollagen, type IV, alpha 3; procollagen, type IV, alpha 4; RATOR; Raw; retinal anterior wiring; Svc; tumstatin; Type IV Collagen |
Clone | 1042 |
Antigène | Collagen IV |
PCNA Monoclonal Antibody (PC10), Alexa Fluor™ Plus 647
PCNA Monoclonal Antibody (PC10), Alexa Fluor™ Plus 647
Applications | Immunohistochemistry (Paraffin) |
---|---|
Type de produit | Antibody |
Isotype | IgG2a |
Conjugué | Alexa Fluor Plus 750 |
Espèces cibles | Human |
Concentration | 0.2 mg/mL |
Primaire ou secondaire | Primary |
Forme | Liquid |
Contenu et stockage | 4°C, store in dark |
État réglementaire | RUO |
Numéro d’ordre du gène | P12004 |
Immunogène | Rat recombinant PCNA polypeptides. |
Expression | Pcna |
Classification | Monoclonal |
Identification génétique (Entrez) | 5111 |
Méthode de purification | Purified |
Espèces hôtes | Mouse |
Symboles de gène(s) | Pcna |
Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Alias de gène | ATLD2; cb16; Cyclin; DNA polymerase delta auxiliary protein; etID36690.10; fa28e03; fb36g03; HGCN8729; hypothetical protein LOC515499; MGC8367; Pcna; pcna protein; Pcna/cyclin; PCNAR; POL30; Proliferating cell nuclear antigen; wu:fa28e03; wu:fb36g03; YBR0811; YBR088C |
Clone | PC10 |
Antigène | PCNA |
Applications | Immunohistochemistry (Paraffin) |
---|---|
Type de produit | Antibody |
Isotype | IgG1 |
Conjugué | Alexa Fluor 420 |
Espèces cibles | Human |
Concentration | 0.2 mg/mL |
Primaire ou secondaire | Primary |
Forme | Liquid |
Contenu et stockage | 4°C, store in dark |
État réglementaire | RUO |
Numéro d’ordre du gène | P02533, P02538, P04264, P05783, P05787, P08727, P08729, P08779, P12035, P13645, P13646, P13647, P19012, P19013, P35908, Q01546, Q04695, Q7Z794 |
Immunogène | Human epidermal keratin. |
Expression | KRT16 |
Classification | Cocktail |
Identification génétique (Entrez) | 374454, 3848, 3849, 3850, 3851, 3852, 3853, 3855, 3856, 3858, 3860, 3861, 3866, 3868, 3872, 3875, 3880, 51350 |
Méthode de purification | Affinity chromatography |
Espèces hôtes | Mouse |
Symboles de gène(s) | KRT1, KRT10, KRT13, KRT14, KRT15, KRT16, KRT17, KRT18, KRT19, KRT2, KRT3, KRT4, KRT5, Krt6a, KRT7, KRT76, KRT77, KRT8 |
Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Alias de gène | 2310016L08Rik; 3300001P10Rik; 39.1; 40-kDa keratin intermediate filament; 47 kDa cytokeratin; 56 kDa cytokeratin; 57kd keratin; 57kDa keratin; 58 kDa cytokeratin; 60-kDa keratin; 63kDa Keratin; 65 kDa cytokeratin; 67 kDa cytokeratin; AA960620; adult keratin; AI324768; AI528832; AI626930; AI663979; AL022697; alpha keratin; AU019895; AW108092; AW146334; basic epidermal type II cytokeratin (carboxy-terminal region, clone pUF164); BB005427; BCIE; BIE; Card2; cell proliferation-inducing gene 46 protein; CK 2e; CK1; CK-1; CK10; CK-10; CK13; CK-13; CK14; CK-14; CK15; CK-15; CK16; CK-16; CK-17; CK18; CK-18; CK19; CK-19; CK-1B; CK-2e; CK3; CK-3; CK4; CK-4; CK5; CK-5; ck55; CK6A; CK-6A; CK6C; CK-6C; CK6D; CK-6D; CK-6E; CK7; CK-7; CK8; CK-8; CYK18; CYK4; CYK8; CYKER; cytokeratin 1; cytokeratin 10; cytokeratin 13; cytokeratin 14; cytokeratin 15; cytokeratin 16; cytokeratin 18; cytokeratin 19; cytokeratin 3; cytokeratin 4; cytokeratin 5; cytokeratin 6A; cytokeratin 6C; cytokeratin 6D; cytokeratin 7; cytokeratin 8; cytokeratin 8 (370 AA); cytokeratin endo A; Cytokeratin endo B; cytokeratin otokeratin; cytokeratin type II; cytokeratin type II, component Ib/c; cytokeratin type II, component III; cytokeratin VIB; cytokeratin VII; cytokeratin-1; Cytokeratin-10; cytokeratin-13; Cytokeratin-14; cytokeratin-15; Cytokeratin-16; cytokeratin-17; Cytokeratin-18; cytokeratin-19; Cytokeratin-1B; Cytokeratin-2e; cytokeratin-3; Cytokeratin-4; cytokeratin-5; Cytokeratin-6A; cytokeratin-6B; cytokeratin-6C; Cytokeratin-6D; cytokeratin-6E; cytokeratin-7; Cytokeratin-8; cytokeratin-A; Cytoskeletal 57 kDa keratin; D130054E02Rik; D15Wsu77e; DDD; DDD1; ear specific cytokeratin; EBS2; ebs3; ebs4; EGK_03684; EGK_03685; EHK; EHK1; Endo B; EndoA; EndoC; epidermal keratin 10; epidermal keratin VII; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; epidermolysis bullosa simplex, Dowling-Meara, Koebner; epidermolytic hyperkeratosis 1; epidermolytic hyperkeratosis; keratosis palmaris et plantaris; epithelial keratin 1; epithelial keratin 10; epithelial keratin 2e; Epithelial keratin-1; Epithelial keratin-2e; EPPK; fgk; fin and gill keratin; FNEPPK; focal non-epidermolytic palmoplantar keratoderma; GK-19; Hair alpha protein; HMWCK; Hom s 5; I79_019823; I79_021074; I79_023185; I79_024335; intermediate filament protein; K1; K10; K13; K14; K15; K16; K17; K18; K19; K1B; K1C1; K1CO; K1CP; K1CS; K2C7; K2C8; K2e; K3; K3 keratin; K4; K5; K6A; K6a keratin; K6C; K6D; K7; K77; K8; Ka10; Ka13; Ka14; Ka15; Ka16; Ka17; Ka19; kamp-keratin derived antimicrobial peptide; Kb1; Kb2; Kb4; Kb7; KDAMP; KER1; Ker10; Ker2; KERA; keratin; keratin 1; keratin 1 (epidermolytic hyperkeratosis); keratin 1, type II; keratin 10; keratin 10 (epidermolytic hyperkeratosis); keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris); keratin 10, type I; keratin 10, type I L homeolog; keratin 10, type I S homeolog; keratin 12, gene 2 S homeolog; keratin 13; keratin 13, type I; keratin 13, type I S homeolog; keratin 14; keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner); keratin 14, type I; keratin 14, type I L homeolog; keratin 15; keratin 15, gene 1 S homeolog; keratin 15, type I; keratin 16; keratin 16 (focal non-epidermolytic palmoplantar keratoderma); keratin 16, type I; keratin 16, type I S homeolog; keratin 17; keratin 17 L homeolog; keratin 17, type I; keratin 17, type I L homeolog; keratin 18; keratin 18, type I; keratin 19; keratin 19 S homeolog; keratin 19 S homeolog; keratin 19; keratin 19, type I; Keratin 1B; keratin 2; keratin 2 (epidermal ichthyosis bullosa of Siemens); keratin 2 epidermis; keratin 2, type II; keratin 24; keratin 2A; keratin 2A (epidermal ichthyosis bullosa of Siemens); keratin 3; keratin 3, type II; keratin 4; keratin 4, type II; keratin 5; keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) |
Clone | AE1/AE3 |
Antigène | Cytokeratin Pan Type I/II |